AU5295899A - Hydroxamic acid derivatives as inhibitors of beta-amyloid production - Google Patents
Hydroxamic acid derivatives as inhibitors of beta-amyloid productionInfo
- Publication number
- AU5295899A AU5295899A AU52958/99A AU5295899A AU5295899A AU 5295899 A AU5295899 A AU 5295899A AU 52958/99 A AU52958/99 A AU 52958/99A AU 5295899 A AU5295899 A AU 5295899A AU 5295899 A AU5295899 A AU 5295899A
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- beta
- acid derivatives
- hydroxamic acid
- amyloid production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9817348.7A GB9817348D0 (en) | 1998-08-11 | 1998-08-11 | Pharmaceutical use of esters |
GB9817348 | 1998-08-11 | ||
PCT/GB1999/002626 WO2000009119A1 (en) | 1998-08-11 | 1999-08-10 | Hydroxamic acid derivatives as inhibitors of beta-amyloid production |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5295899A true AU5295899A (en) | 2000-03-06 |
Family
ID=10836978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52958/99A Abandoned AU5295899A (en) | 1998-08-11 | 1999-08-10 | Hydroxamic acid derivatives as inhibitors of beta-amyloid production |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1105116A1 (en) |
JP (1) | JP2002522489A (en) |
AU (1) | AU5295899A (en) |
GB (1) | GB9817348D0 (en) |
WO (1) | WO2000009119A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10043282A1 (en) * | 2000-09-02 | 2002-03-28 | Kurt Heininger | Medicaments containing amyloid-beta-protein formation and/or secretion inhibitors, are used for treating hypertension, diabetes, arteriosclerosis, rheumatism, cardiac infarction, inflammation or sepsis |
NZ594561A (en) * | 2009-03-19 | 2013-03-28 | Bristol Myers Squibb Co | A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
US20200121666A1 (en) * | 2017-06-05 | 2020-04-23 | The Methodist Hospital System | Tau phosphorylation inhibitors and methods for treating or preventing alzheimer's disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0925278B1 (en) * | 1996-09-10 | 2002-07-17 | British Biotech Pharmaceuticals Limited | Cytostatic hydroxamic acid derivatives |
-
1998
- 1998-08-11 GB GBGB9817348.7A patent/GB9817348D0/en not_active Ceased
-
1999
- 1999-08-10 AU AU52958/99A patent/AU5295899A/en not_active Abandoned
- 1999-08-10 WO PCT/GB1999/002626 patent/WO2000009119A1/en not_active Application Discontinuation
- 1999-08-10 JP JP2000564622A patent/JP2002522489A/en active Pending
- 1999-08-10 EP EP99938450A patent/EP1105116A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2002522489A (en) | 2002-07-23 |
EP1105116A1 (en) | 2001-06-13 |
WO2000009119A1 (en) | 2000-02-24 |
GB9817348D0 (en) | 1998-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7412196A (en) | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of beta-amyloid protein production | |
AUPP868599A0 (en) | Production of isoflavone derivatives | |
AU4862999A (en) | Method of vitamin production | |
AU2754501A (en) | Treatment of acne using lipoic acid | |
AU4589297A (en) | Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase | |
HUP0101793A3 (en) | Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase | |
AU4458700A (en) | Uses of phenylglycine derivatives | |
AU6487600A (en) | Process for production of an etheralcohol | |
AU5634999A (en) | Hydroxamic acid derivatives as proteinase inhibitors | |
AU6229699A (en) | Beta-amyloid formation inhibitors | |
PL342817A1 (en) | Novel derivatives of dihydroxyhexanic acid | |
IL139884A0 (en) | N-substituted derivatives of 5-oximinobarbituric acid | |
AU3703199A (en) | Process for production of acetic acid | |
AU2001267416A1 (en) | N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23 | |
AUPQ385099A0 (en) | Production of thin steel strip | |
AU7445100A (en) | Sebum production inhibitors | |
AU5295899A (en) | Hydroxamic acid derivatives as inhibitors of beta-amyloid production | |
AU6108399A (en) | Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins | |
AU4750000A (en) | Method for production of microcapsules | |
AU7958000A (en) | Process for the preparation of oxyiminoalkanoic acid derivatives | |
PL332450A1 (en) | Method of obtaining derivatives of hydroxamic acid | |
AU2370400A (en) | Methods for the synthesis of alpha-hydroxy-beta-amino acid and amide derivatives | |
AU8005100A (en) | Inhibitors of neuraminidases | |
AU7608100A (en) | 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors | |
AU3299900A (en) | Method for the production of aliphatic fluoroformates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |